Next Article in Journal
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
Previous Article in Journal
Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
Previous Article in Special Issue
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
Open AccessEditorial

What Is the Fuss about Integrins and the Tumor Microenvironment?

1
Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Waldeyerstr. 15, 48149 Münster, Germany
2
Department of Biomedicine and Centre for Cancer Biomarkers, University of Bergen, Jonas Lies vei 91, NO-5009 Bergen, Norway
*
Authors to whom correspondence should be addressed.
Cancers 2019, 11(9), 1296; https://doi.org/10.3390/cancers11091296
Received: 27 August 2019 / Accepted: 28 August 2019 / Published: 3 September 2019
(This article belongs to the Special Issue The Role of Integrins in Cancer)
Note: In lieu of an abstract, this is an excerpt from the first page.

In recent years the tumor microenvironment (TME) has received increasing attention [...] View Full-Text
MDPI and ACS Style

Eble, J.A.; Gullberg, D. What Is the Fuss about Integrins and the Tumor Microenvironment? Cancers 2019, 11, 1296. https://doi.org/10.3390/cancers11091296

AMA Style

Eble JA, Gullberg D. What Is the Fuss about Integrins and the Tumor Microenvironment? Cancers. 2019; 11(9):1296. https://doi.org/10.3390/cancers11091296

Chicago/Turabian Style

Eble, Johannes A.; Gullberg, Donald. 2019. "What Is the Fuss about Integrins and the Tumor Microenvironment?" Cancers 11, no. 9: 1296. https://doi.org/10.3390/cancers11091296

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop